London-listed Croda International is acquiring Biosector, a company specialising in manufacturing adjuvants, which are used to improve the efficacy of vaccines.
Croda International was originally founded in 1925 and develop products for multiple sectors including construction, pharmaceuticals and textiles. The Yorkshire-based group has agreed with Brenntag Nordic to acquire its subsidiary Brenntag Biosector, which focuses on producing and developing vaccine adjuvants in both human and veterinary vaccines. The Danish company was founded in…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
